Flavored vapes and the controversy dividing the FDA
Three health policy researchers break down the science behind flavored vapes—and what the FDA leadership shake-up means for public health—in this piece written for The Conversation.
Holly Jarman Results
Brexit Puts UK Health Care at Risk
New Report from Holly Jarman and Scott Greer
The future for the health sector in the United Kingdom is perilously uncertain, according to a report led by Holly Jarman and Scott Greer, professors of Health Management and Policy at Michigan Public Health.
IN THE NEWS: Where Did Tackling COVID-19 Go Wrong for the US?
Holly Jarman featured on CNN
University of Michigan School of Public Health professor Holly Jarman tells Fareed Zakaria of CNN that a "fragmented" public health system has hurt the US response to COVID-19.
Future of UK's Health Care System Uncertain as Brexit Moves Forward Amid COVID-19
Q&A with Holly Jarman and Scott Greer
While COVID-19 has been garnering the attention of leaders around the world, the transition period for Brexit ends Dec. 31, 2020. A group of researchers, including Holly Jarman and Scott Greer from University of Michigan's School of Public Health recently analyzed the negotiating position in assessing the potential impact on health of the United Kingdom's future relationship agreement with the European Union.
Raising Tobacco Purchase Age to 21 Would Prevent Thousands of Premature Deaths in Michigan
New Research from Holly Jarman and Rafael Meza
Restricting sales of tobacco products to people 21 and older could keep 11,000 Michiganders from starting to smoke, potentially avoiding premature deaths in two-thirds of that population, according to a University of Michigan study.
No-Deal Brexit Will Have Serious Negative Health Effects
New Research from Holly Jarman
A no-deal Brexit would make it harder for the United Kingdom to recruit health workers into their system, will jeopardize continuing care for British citizens with pre-existing conditions living outside the U.K., and could even lead to an increase in cardiovascular disease-related deaths, say researchers.